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Presently the majority of tissue engineering approaches aimed at regenerating bone relies only on post-
implantation vascularization. Strategies that include seeding endothelial cells (ECs) on biomaterials
and promoting their adhesion, migration and functionality might be a solution for the formation of
vascularized bone. Nano/micro-ﬁber-combined scaffolds have an innovative structure, inspired by
extracellular matrix (ECM) that combines a nano-network, aimed to promote cell adhesion, with
a micro-ﬁber mesh that provides the mechanical support. In this work we addressed the inﬂuence of
this nano-network on growth pattern, morphology, inﬂammatory expression proﬁle, expression of
structural proteins, homotypic interactions and angiogenic potential of human EC cultured on a scaffold
made of a blend of starch and poly(caprolactone). The nano-network allowed cells to span between
individual micro-ﬁbers and inﬂuenced cell morphology. Furthermore, on nano-ﬁbers as well as on
micro-ﬁbers ECs maintained the physiological expression pattern of the structural protein vimentin and
PECAM-1 between adjacent cells. In addition, ECs growing on the nano/micro-ﬁber-combined scaffold
were sensitive to pro-inﬂammatory stimulus. Under pro-angiogenic conditions in vitro, the ECM-like
nano-network provided the structural and organizational stability for ECs’ migration and organization
into capillary-like structures. The architecture of nano/micro-ﬁber-combined scaffolds elicited and
guided the 3D distribution of ECs without compromising the structural requirements for bone
regeneration.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
To become widely used in clinical practice tissue engineering
products must overcome a series of major challenges, the vascu-
larization of the biomaterial constructs being one of the major
current limitations [1–3]. To date, most approaches in tissue engi-
neering have relied on post-implantation neovascularization from
the host, but for large and metabolically demanding organs, which
rely on blood vessel ingrowth, this is clearly insufﬁcient tomeet the
implant’s demand for oxygen and nutrients [4–6].
In vascularized tissues/organs such as bone a complex network
of blood vessels is more than just simple conduits that provide
nutrients and oxygen and simultaneously remove by-products.
They also have important metabolic and rheological functions: þ49 6131 17477301.
atrick).
All rights reserved.which are organ-speciﬁc [7–9]. In bone, the intraosseous circula-
tion allows trafﬁc of minerals between the blood and bone tissue,
and transmits the blood cells produced within the bone marrow
into the systemic circulation [9,10]. New blood vessels are inti-
mately involved in osteogenesis (intramembranous and endo-
chondral) and, furthermore, cytokines and growth factors that
regulate intraosseous angiogenesis also regulate bone remodelling
[7,9]. In addition, vascularization is also vital for the survival of the
implanted cells on the carrier material after implantation [6].
Many approaches have been proposed to increase vasculariza-
tion in bone such as gene and/or protein delivery of angiogenic
growth factors [11,12], provision of a vascularized bone ﬂap [13,14]
and ex vivo culturing of scaffolds with ECs alone or in combination
with other cell types [6,15]. Recently the work of Levenberg et al. on
skeletal muscle showed that pre-vascularization of constructs
improved in vivo performance of the tissue construct, shedding
light into ex vivo use of ECs to accelerate vascularization [16]. Thus,
the scaffold design must not only take into consideration the
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sion, migration and blood vessel formation and ingrowth. In blood
vessels ECs are attached as a monolayer to a basement membrane
composed of protein ﬁbers in the nanoscale, such as type IV
collagen and laminin ﬁbers, embedded in heparin sulfate proteo-
glycan hydrogels [17,18]. This natural extracellular matrix (ECM)
provides structural and organizational stability to ECs and during
angiogenesis EC migration is dependent on the adhesion to this
matrix [19].
In this present work we evaluate the interaction of ECs with
a scaffold made from a blend of starch with poly(caprolactone)
(SPCL) with an innovative structure, inspired by the ECM, and
combining polymeric micro- and nano-ﬁbers in the same construct.
This architecture was designed for bone regeneration to simulta-
neously provide mechanical support and to mimic the physical
structure of ECM. We hypothesized that the presence of a nano-
network might favour the adhesion of ECs and increase the density
of cell colonization between micro-ﬁbers, and might thus accel-
erate vascularization of the implanted scaffold. Previous work
demonstrated favourable activity and differentiation of bone-like
cells on this nano/micro-ﬁber-combined scaffold [20]. In this paper
we addressed several important biological questions, such as
whether this nano-network favours the growth pattern of ECs on
the scaffold, cell morphology, inﬂammatory gene expression
proﬁle, expression of structural proteins and ﬁnally the angiogenic
potential.
2. Materials and methods
2.1. Scaffolds
The scaffolds used in this study were based on a blend of starch with poly
(caprolactone) (SPCL, 30/70 wt%). Nano/micro-ﬁber-combined scaffolds resulted
from a two-step methodology. First by a ﬁber bonding methodology an SPCL ﬁber-
mesh scaffold composed of micro-ﬁbers (B160 mm) with 70% porosity was obtained
and second, by electrospinning the scaffold was impregnated with nano-ﬁbers
(B400 nm). SPCL ﬁber-mesh scaffold without the nano-network was used as
control. Further details concerning scaffold production have been published else-
where [20–22]. Samples were cut into discs of 8 mm diameter and 2 mm height and
sterilized by ethylene oxide. Prior to cell seeding scaffolds were soaked overnight in
medium without serum.
2.2. Cells, culture conditions and scaffold seeding
Primary cultures of human ECs isolated from umbilical cord (human umbilical
vein EC/HUVEC) and from human dermis (human dermal microvascular
EC/HDMEC) were used. HUVECs were isolated from umbilical vein by collagenase
digestion according to a published method [23]. HDMECs were obtained from
enzymatic digestion of juvenile foreskin as previously described [24]. HUVECs were
cultured in M199 medium (Sigma–Aldrich, Germany) supplemented with 20% fetal
calf serum (FCS; Gibco, Germany), 100 U/100 mg/mL Pen/Strep (Sigma–Aldrich,
Germany), 2 mM glutamax I (Life Technologies, Germany), 25 mg/mL sodium heparin
(Sigma–Aldrich, Germany) and 25 mg/mL endothelial cell growth supplement
(ECGS, BD Biosciences, USA). HDMECs were cultivated in Endothelial Basal Medium
MV (PromoCell, Germany) supplemented with 15% FCS (Invitrogen, Germany),
100 U/100 mg/mL Pen/Strep (Sigma–Aldrich, Germany), 2.5 ng/mL basic ﬁbroblast
growth factor (bFGF; Sigma–Aldrich, Germany), 10 mg/mL sodium heparin and
100 U/100 mg/mL Pen/Strep. In order to promote better cell adhesion, ECs were
seeded into culture ﬂasks previously coated with gelatine. All assays were con-
ducted with cells until passage 4.
Prior to cell seeding scaffolds were coated with a ﬁbronectin solution (10 mg/mL
PBS, Roche, Germany) for 1 h at 37 C. Conﬂuent HUVECs and HDMECs were tryp-
sinized and a suspension of 2105 cells was added to each scaffold. The scaffolds
were incubated under standard culture conditions (37 C, 5% CO2, humidiﬁed
atmosphere).
2.3. ECs’ imaging
The viability, phenotype and growth of ECs on nano/micro-ﬁber-combined
scaffolds and on SPCL ﬁber-mesh scaffolds were analyzed by scanning electron
microscopy [25] and by confocal laser scanning microscopy (CLSM) after 3 and 7
days. For viability assessment, the EC-seeded scaffolds were incubated for 10 min in
medium supplemented with 0.1 mM calcein-AM. Viable cells convert the non-ﬂuo-
rescence and membrane permeable calcein-AM due to the presence of activeintracellular esterases into the green ﬂuorescent and impermeable calcein. Viable
cells are identiﬁable by the green ﬂuorescent cytoplasm when viewed with CLSM
(Leica TCSN NT). For SEM analysis the samples were ﬁxed for 30 min with 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer, dehydrated in increasing
concentrations of acetone, dried with hexamethyldisilazane and sputter coatedwith
gold prior to SEM observation (Leica Cambridge S360).2.4. Gene analysis of pro-inﬂammatory genes
The gene analysis of two pro-inﬂammatory cell adhesion molecules E-selectin
and intercellular adhesion molecule (ICAM-1) was carried out by Real-time PCR. The
mRNA expression of cell adhesion molecules as well as the housekeeping gene
GAPDHwas analyzed in HUVECs growing for 7 days on SPCL ﬁber-mesh scaffold and
on nano/micro-ﬁber-combined scaffold. As control HUVECs were grown on cell-
culture plastic. Furthermore, as positive control, gene expression was analyzed
when the samples were cultured in the presence of 1.0 mg/mL of lipopolysaccharide
(LPS) for 4 h (Sigma–Aldrich, Germany). Total mRNA fromHUVEC cells was extracted
using the RNeasy Mini Kit (Qiagen, Germany) according to the manufacturer’s
protocol. Afterwards, total RNA (0.5 mg) was reverse transcribed using Omniscript RT
Kit (Qiagen, Germany). Gene ampliﬁcationwas performed using Applied Biosystems
7300 Real-Time PCR System (Applera Deutschland GmbH, Germany). The number of
cycles and annealing temperature were selected according to the manufacturer’s
instructions. Real-time PCR was performed with 2.5 ng cDNA and 12.5 mL of 2
master mix, primers (0.25 mL forward and 0.25 mL reverse primer) in a ﬁnal volume
of 25 mL. The following gene-speciﬁc primer sets were used: (1) E-selectin, sense 50-
CCCGTGTTTGGCACTGTGT-30 , antisense 50-GCCATTGAGCGTCCATCCT-30; (2) ICAM-1,
sense 50-CGGCTGACGTGTGCAGTAAT-30 , antisense 50-CACCTCGGTCCCTTCTGAGA-30;
(3) GAPDH, sense 50-ATGGGGAAGGTGAAGGTCG-30 , antisense 50-TAAAAG-
CAGCCCTGGTGACC-30 . Gene expression was normalized to the expression of the
housekeeping gene GAPDH. Relative quantiﬁcation of gene expression was calcu-
lated in stimulated samples (þLPS) compared to samples cultured in the absence of
pro-inﬂammatory stimulus (LPS).2.5. Immunocytochemistry
The expression pattern of the structural protein vimentin and of the platelet
endothelial cell adhesion molecule (PECAM-1, CD31) was examined by immuno-
cytochemistry. After 7 days in culture, EC-conﬂuent SPCL scaffolds were ﬁxed with
a solution of 2% paraformaldehyde for 30 min at room temperature (RT). Samples
were rinsed in PBS and then treatedwith PBS-buffered 0.1% Triton X-100 for 5 min at
RT to permeabilize the cell membranes for the antibody reactions. The samples were
incubated for 45 min at RT with the primary antibodies: mouse anti-human PECAM-
1 (1:50, Dako, Denmark) or mouse anti-human vimentin (1:200, Sigma–Aldrich,
Germany). Following PBS washing, a second incubationwas performed for 45 min at
RT with the secondary antibody anti-mouse Alexa Fluor 488 (Invitrogen, Germany).
The nuclei were counterstained with 1 mg/mL Hoechst in PBS for 5 min. SPCL ﬁber
meshes were then washed with PBS, mounted with Gel/Mount (Natutec, Germany)
and visualized by CLSM.2.6. Induction of angiogenesis in vitro
The angiogenic potential of HDMEC growing on SPCL ﬁber-mesh scaffolds was
assessed by observing the cell migration from the scaffold into a collagen type I gel
that mimics the in vivo microenvironment. When HDMECs reached conﬂuence on
the scaffolds the scaffolds were transferred to a Petri dish and coveredwith a 1.5 mg/
mL solution of collagen type I in M199 medium containing 2% sodium bicarbonate,
0.05 M NaOH and 200 nM HEPES. As soon as the solution solidiﬁed into a gel, culture
medium supplemented with angiogenic growth factors 50 ng/mL vascular endo-
thelial growth factor (VEGF; Biomol, Germany) and 10 ng/mL bFGF was added. After
an additional 7 days in culture, materials were examined for the migration of ECs
and organization into capillary-like structures after calcein-AM live-staining and
visualization by CLSM. All the above-referred reagents were from Sigma–Aldrich,
Germany.
In order to have a better perception of the spatial distribution of capillary-like
structures and micro-ﬁbers the confocal images were post-processed using the
image processing software ITK-SNAP [26]. Individual confocal image stacks from
nano/micro-ﬁber-combined scaffold composed of 99 sections were examined.
Capillary-like structures were identiﬁed and labelled in green and red, respectively,
using the manual segmentation tool and the segmented elements were processed
into a ﬁnal 3D image.
Aimed at the evaluation of EC ultrastructure, transmission electron microscopy
(TEM) of collagen gel ultrathin sections was performed. Scaffolds plus collagen gel
were ﬁxed in 2.5% glutaraldehyde in cacodylate buffer, post-ﬁxed in 1% osmium
tetroxide for 2 h and dehydrated in increasing ethanol concentration. Samples were
embedded in agar resin 100 (PLANO, Germany) with ethanol as solvent for transition
state and subjected to polymerization at 60 C for 48 h. Ultrathin sections were cut,
placed onto copper grids and examined by transmission electron microscope (Phi-
lips EM 410).
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3.1. Growth, viability and phenotype of ECs on starch-based
scaffolds
ECs of microvascular origin, HDMECs as well as the macro-
vascular HUVECs grew on both ﬁbronectin-coated nano/micro-
ﬁber-combined scaffolds and on SPCL micro-mesh scaffolds.Fig. 1. Confocal ﬂuorescent micrographs of viable HDMECs (A, B, D, E) and HUVECs (C, F) gro
micro-ﬁber scaffold (right column) after 3 (A, D, C, F) and 7 days (B, E). Cells were stained wit
nano- and micro-ﬁbers. The values of the scale bars are: (A) 208 mm, (B, D, E) 300 mm, (C,Growth was observed on both micro- and nano-ﬁbers (Fig. 1). The
requirement of a pre-coating with ﬁbronectin or other ECM
molecule for EC adhesion to several substrates has been widely
reported [27–29]. On nano/micro-ﬁber-combined scaffolds, after 3
days of culture HDMEC spanned between adjacent micro-ﬁbers
using the nanobridges formed by the nano-ﬁbers, thus yielding
a high density of adherent ECs (Fig. 1A). After 7 days, nearly
complete growth on the surface areas of the scaffold was observedwing on ﬁbronectin-coated nano/micro-ﬁber-combined scaffolds (left column) and on
h the vital ﬂuorochrome calcein-AM. Good cell growth is seen for both EC types on both
F) 600 mm.
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remained viable as proven by the ability to convert calcein-AM into
a green ﬂuorescent compound. On the other hand, on the scaffold
without the nano-network, cells were detected on the micro-ﬁbers
after 3 days as well as after 7 days, but no cells were seen to span
between the ﬁbers (Fig. 1D and E).
Cell adhesion studies were also performed with primary
cultures of macrovascular ECs, HUVECs. HUVECs seeded onto nano/
micro-ﬁber-combined scaffolds rapidly covered the entire surface
of the nano-network without signiﬁcantly impairing the scaffold
porosity (day 3, Fig. 1C). On the other hand, viable HUVECs adhered
to the individual ﬁbers on SPCL micro-ﬁber-mesh scaffold (Fig. 1F).
Phenotype of HUVECs was assessed by SEM after 3 days of
culture. ECs adhered to the randomly electrospun nano-network as
well as to micro-ﬁbers and cells used the nano-ﬁbers to bridge
empty spaces in the micro-ﬁber mesh (Fig. 2A). In contrast, the
SPCL micro-ﬁber-mesh scaffold did not induce cell spanning across
the construct (Fig. 2C). Morphologically, ECs on micro-ﬁbers
exhibited the typical ﬂattened phenotype of ECs (Fig. 2C) whereas
the nano-network induced a different cytoskeletal arrangement
reﬂected in the stretched shape and numerous cellular protrusions
(Fig. 2A). Besides improving the interconnectivity in the scaffold,
nano/micro-ﬁber-combined scaffolds also provided a unique
physical support that allows the growth of ECs into circular
arrangements that resemble the morphology of capillary-like
structures (Fig. 2B).Fig. 2. SEM micrographs of HUVEC cells on ﬁbronectin-coated SPCL scaffolds: (A, B)
nano/micro-ﬁber-combined scaffold and (C) micro-ﬁber scaffold after 3 days of culture.
Note the ability of the EC to use the nanoﬁbers to span across the micro-ﬁber structure.3.2. Expression of genes involved in the inﬂammatory response
In blood vessels the endothelium functions as a dynamic and
actively transporting barrier, which under special conditions, such
as inﬂammation, mediates leukocyte recruitment by the expression
of different cell adhesion molecules like ICAM-1 (intercellular
adhesion molecule-1) and selectins. Utilizing Real-time PCR the
expression of two cell adhesion molecules E-selectin and ICAM-1
on HUVECs growing on nano/micro-ﬁber-combined scaffolds was
analyzed and compared with the expression on control scaffolds
(SPCL micro-ﬁber-mesh scaffold without nano-ﬁbers). HUVECs
grown on tissue culture plastic served as control (Fig. 3). ECs
growing on the three substrates reacted in a similar way when
exposed to the pro-inﬂammatory stimulus LPS, increasing the
levels of mRNA that code for ICAM-1 and E-selectin. As a common
pattern it was observed that the up-regulation of E-selectin was
higher than ICAM-1 in response to LPS. This lower level of up-
regulation of ICAM-1 relatively to E-selectin is probably due to the
constitutive expression of this cell adhesion molecule on ECs and
consequently to a minor difference between the basal and stimu-
lated state. With respect to the combined scaffold, the presence in
the same construct of micro- and nanometric ﬁber size did not
affect the ability of ECs to properly respond to pro-inﬂammatory
stimuli through the up-regulation of these genes related to the
capture of circulating leukocyte, this representing an essential
stage in the physiological inﬂammatory reaction.3.3. Expression of the structural protein vimentin and the
cell–cell adhesion molecule PECAM-1
Cell structure and the interactions with neighbouring cells are
important aspects to take into consideration in studying cell
functionality. Thus, the expression of vimentin, an intermediate
ﬁlament protein present in mesenchymal cells and of PECAM-1 (CD
31), a cell adhesion molecule present predominantly at the inter-
cellular junctions was assessed by immunocytochemical staining.
Fig. 4A shows that on nano-ﬁbers, endothelial vimentin ﬁlaments
are more stretched, but no disruption of this structural protein wasobserved. Elongated, vimentin-stained cells populated the entire
scaffold and grew along both nano- and micro-ﬁbers.
A typical PECAM-1 expression pattern (a peripheral ring
surrounding cells at cell–cell interfaces) was observed on both
nano-micro-ﬁber-combined scaffolds and on control scaffolds
(Fig. 4B and C). ECs on nano-ﬁbers as well as on micro-ﬁbers
continued to express this major cell adhesion molecule. This indi-
cates that despite the differences in the dimensions of the under-
lying substratum ECs can still establish contact with adjacent cells.
3.4. Angiogenic potential of ECs on starch-based scaffolds
In a more complex in vitro assay, the ability of ECs in contact to
the scaffolds to invade into and to form capillary-like structures
Fig. 3. Relative quantiﬁcation of E-selectin and ICAM-1 mRNA in HUVECs grown on
nano/micro-ﬁber scaffolds and on micro-ﬁber scaffolds in the presence of LPS (þLPS)
compared with the growth in the absence of pro-inﬂammatory stimulus (LPS). As
a control the expression of these inﬂammatory genes was assessed on HUVECs
growing on cell-culture plastic.
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assayed. To visualize the cells within the 3D-matrix a calcein-AM
staining was necessary. This staining revealed that ECs were able to
migrate from the scaffold and invade into the collagen gel on both
nano/micro-ﬁber-combined scaffolds as well as in control scaffolds,
after 7 days of culture (Fig. 5). However, a different behavior
between the two scaffolds was observed. On the micro/nano-ﬁber-
combined scaffold, ECs formed more capillary structures with
branching (Fig. 5A). In contrast, on the scaffolds without the nano-
network, ECs formed fewer capillary-like structures with less
branching (Fig. 5C).
The 3D reconstitution of the segmented micro-ﬁbers and
capillary-like structures from the confocal stack images of nano/
micro-ﬁber-combined scaffold (Fig. 5A is the projection) provided
further information. It was shown that the tubular structures
formed by ECs were present at different depths, and that there was
a spatial separation between the capillary-like structures and the
micro-ﬁbers along the Z axis (Fig. 5D). Thus, this further reinforces
the ability of ECs to migrate out of the scaffold into the collagen
matrix and to organize into capillary-like structures.
The ultrastructure of ECs assessed by TEM revealed the exis-
tence of adherent junctions between ECs, denoting the intimate
contact between angiogenesis-stimulated cells (Fig. 6A). At a higher
magniﬁcation numerous vesicles were visible, indicative of the
highly active state of the ECs (Fig. 6B).4. Discussion
Tissue engineering scaffolds should function as temporary ECMs
and until repair or regeneration occurs they should aim to mimic
native ECM both architecturally and functionally [30]. In physio-
logical tissue re-organization (e.g. during wound healing) the
bidirectional ﬂow of information exchanged between cells and ECM
steers important cell functions such as adhesion, differentiation
and migration [31]. Thus, it can be suggested that the more a scaf-
fold can resemble ECM, the more successful the scaffold can be. To
date, electrospinning has been one of the main processing tech-
niques used in the fabrication of structures in the nanometer range.
This ﬁber spinning technique produces polymer ﬁbers withdiameters down to a few nanometers and nano-ﬁbers obtained by
electrospinning have been proposed for engineeringmany different
tissues [32]. However, electrospun scaffolds retain several prob-
lems such as three-dimensional cell growth restricted to a depth of
100 mm, lack of control of pore diameter and distribution, as well as
low stiffness [33].
Tuzlakoglu et al. proposed nano/micro-ﬁber-combined scaf-
folds, a matrix that combines two structures: (i) a nano-network
produced by electrospinning, thatmimics ECM and aims to increase
cell adhesion and motility; with (ii) a micro-ﬁber-mesh produced
by ﬁber bonding aimed to give the mechanical support required
during repair [20]. This latter structure, an SPCL ﬁber-mesh scaffold,
was used in this work as a control and it was previously described
by our group as a promising biomaterial for bone regeneration
[21,34,35]. Studies with bone marrow cells cultured under dynamic
conditions on SPCL ﬁber-mesh scaffolds showed that cells differ-
entiated into osteoblasts deposited a mineralized matrix and
produced several bone growth factors [21,34,35]. Furthermore,
previous work with ECs revealed that they maintained their
genotypic and phenotypic patterns when growing on SPCL ﬁber-
mesh scaffolds [36].
Based on the previous studies that have proven the suitability of
nano/micro-ﬁber-combined scaffold for osteoblast differentiation
and activity [20], the present work deals with the inﬂuence this
ECM-like architecture has on EC growth pattern, homo- and
heterotypic interactions and on angiogenic potential.
Cell adhesion studies with HDMECs and HUVECs revealed that
both cell types adhere and remain viable on ﬁbers in the nano- as
well as in the micrometer range. In fact, in the nano/micro-ﬁber-
combined scaffold the existence of a structure that resembles the
physical structure of ECM furnishes the physical points required for
ECs to span between the bulk structure of the scaffold without
compromising the porosity and interconnectivity of the structure.
Moreover, these nanometer dimensions are reﬂected in individual
cell phenotype and overall cellular rearrangement. On the micro-
ﬁbers the cells exhibit the same ﬂattened morphology character-
istic of their location inside larger blood vessels. By contrast, on the
nano-network ECs present an extremely stretched shape reminis-
cent of the angiogenic phenotype, with multiple cellular protru-
sions anchoring them to several nano-ﬁbers. This stretched
phenotype might be beneﬁcial as it was reported that ECs
spreading or elongating show increased sensitivity to speciﬁc
growth factors such as bFGF [37]. Furthermore, the nano-ﬁbers
allow a more comprehensive arrangement of ECs positioned within
the scaffolds when compared with the scaffolds without nano-
ﬁbers. Thus, ECs could be easier available for blood vessel formation
after implantation of constructs. Of special interest is the capability
of the adherent cells to use the physical support provided by the
nano-network to adhere and spread into circular arrangements
that morphologically resemble capillary-like structures.
Bone tissue-engineered constructs should not only induce good
phenotypic properties in ECs such as spreading morphology, cell
viability, and cell attachment but also encourage ECs’ cell functions,
which can be assessed through the expression of cell–cell adhesion
molecules involved in heterotypic (cell adhesion molecules such as
ICAM-1) and homotypic (PECAM-1) interactions as well as in
migration studies. Concerning the heterotypic interactions, ECs
play a key role during the inﬂammatory response through the
sequential expression of cell adhesion molecules [38]. These
molecules recognize speciﬁc ligands on circulating leukocytes and
help them to transmigrate across the endothelium towards the pro-
inﬂammatory stimuli, thus enabling inﬂammation. In a scaffold for
tissue regeneration it is necessary that in the presence of a pro-
inﬂammatory stimulus, such as cytokines like TNF-a or bacterial
compounds like endotoxins, ECs possess the potential to participate
through the expression of adhesion molecules for leukocytes. That
Fig. 4. Immunoﬂuorescence micrographs of vimentin (A) and PECAM-1 staining (B, C) (green ﬂuorescence) in HUVEC cells grown on nano/micro-ﬁber-combined scaffold (A, B) and
on micro-ﬁber scaffold (C). Nuclei were counterstained with Hoechst (blue ﬂuorescence). The values of the scale bars are: (A) 68 mm, (B) 75 mm, (C) 150 mm.
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during an inﬂammatory response but in the absence of an
inﬂammatory stimulus should not induce up-regulation of cell
adhesion molecules. This last situation could lead to a continu-
ously inﬂammatory activated endothelium and consequently to
a massive recruitment of leukocytes and increased vascular
permeability. To this end, the possible interference of the nano/
micro-ﬁber-combined scaffold on gene expression of two cell
adhesion molecules characteristic for pro-inﬂammatory activation
of ECs, E-selectin and ICAM-1, was analyzed by Real-time PCR. The
results showed the ability of ECs on nano/micro-ﬁber-combined
scaffold to up-regulate the expression of ICAM-1 and E-selectin in
response to the pro-inﬂammatory stimulus LPS, following the same
pattern observed for the scaffold- and tissue culture plastic
controls. This not only suggests the capacity of cells growing on
nano/micro-combined scaffolds and on control scaffolds to partic-
ipate in the inﬂammatory response through the expression of
pro-inﬂammatory genes, but also indicates that under normal
conditions (absence of LPS) the growth of ECs on these scaffolds
does not appear to affect the expression of these genes.
The interendothelial interactions of endothelial cells on the
scaffolds were evaluated by PECAM-1 distribution pattern. When
studying the interaction of tissue-engineered scaffolds with ECs it
is important to assess PECAM-1 distribution pattern, not only
because it is a major endothelial marker but also due to the key role
this protein plays in endothelial barrier integrity and in leukocytetransmigration during the inﬂammatory response [39]. On SPCL
ﬁbers in the nano- and micro-range, PECAM-1 is present predom-
inantly in the contact sites at cell–cell borders. These cell–cell
contact sites are a positive indication of the adequate inter-
endothelial contacts established between adjacent cells when
growing and are typical of a quiescent (non-stimulated) endothe-
lium. This is particularly relevant for the nano-network as the
effects of electrospun nano-ﬁbers on the phenotypic behavior of
a variety of cell types have been previously reported [30]. In order
to examine endothelial cell structure we performed immuno-
staining for vimentin on cells growing on ﬁbers. Vimentin is an
intermediate ﬁlament protein responsible for maintaining cell
shape, integrity of the cytoplasm, and stabilizing cytoskeletal
interactions [40]. Vimentin ﬁlaments in the cells growing on the
nano-network were more stretched than those on micro-ﬁbers but
exhibited no apparent disruption of cell structural integrity.
A successful scaffold for bone regeneration must not only
promote osteogenesis but also promote the development of
a vascular network. Post-natal vascularization occurs mainly by
angiogenesis, which is a multi-stage process characterized by an
orderly sequence of events including matrix degradation, EC
migration, proliferation and formation of new basementmembrane
components [41]. Migration is driven chemotactically via gradients
of cytokines or other agonists but it is the ﬁbrillar structure of ECM
in the nanometer range of dimensions that provides the physical
cues to proliferating and migrating ECs to organize and form new
Fig. 5. CLSM of capillary-like structures formed by angiogenesis-stimulated HDMECs from nano/micro-ﬁber-combined scaffold (A, B, D) and from micro-ﬁber scaffold (C). (B) The
higher magniﬁcation of the square highlighted in (A). (D) The 3D reconstruction from the manual segmentation of micro-ﬁbers and capillary-like structures on the sections that
make up (A). Scaffolds were cultured for 7 days with HDMECs and then covered with a type I collagen gel and cultured for a further 7 days. White arrows indicate some of the
capillary-like structures. The values of the scale bars are: (A) 300 mm, (B) 150 mm, (C) 300 mm.
M.I. Santos et al. / Biomaterials 29 (2008) 4306–431343123D capillary networks [19]. The angiogenic potential of ECs on the
scaffold with ECM-like structure under a pro-angiogenic environ-
ment was examined in order to determine if nano-structures
affected this process. ECs migrated from both scaffolds into the
collagen gel, but there appeared to be an elevation in migration and
3D organization into capillary-like structures in the nano/micro-Fig. 6. Transmission electron micrograph of migrating ECs from nano/micro-combined sca
intimate contact between two ECs.combined scaffold. This achievement in the later scaffold could be
due to the increased surface area, the ECM-like structure and to the
elongated cell morphology. Folkman et al. reported that conﬂuent
ECs are refractory to growth factors, whereas stretched or elon-
gated ECs have increased sensitivity to growth factors, such as bFGF
[37]. These ﬁndings might indicate that stretched cells on nano-ffold to collagen gel, in a pro-angiogenic environment. The black arrow indicates the
M.I. Santos et al. / Biomaterials 29 (2008) 4306–4313 4313ﬁbers are more responsive to angiogenic growth factors thus
organizing more easily into capillary-like structures, than conﬂuent
and less sensitive cells on micro-ﬁbers. Whether this is the case,
needs to be investigated in further studies which quantitate the
complex three-dimensional reaction.5. Conclusion
The incorporation of structures that physically mimic the ECM,
i.e., nano-networks on micro-ﬁber meshes, not only increased the
adhesion surface area and interconnectivity in the constructs but
also provided structural and organizational stability for ECs. Using
nano-ﬁbers as bridges both human micro- and macrovascular ECs
spanned between micro-ﬁbers exhibited a more stretched pheno-
type when compared with the scaffold without nano-ﬁbers.
Furthermore, once the nano-ﬁbers allowed a comprehensive
arrangement of ECs in the in vitro constructs, ECs could be easier
available for bloodvessel formation after implantationof constructs.
Furthermore, ECs on nano- as well onmicro-ﬁbersmaintained their
structural integrity (vimentin) and their intercellular contacts
(PECAM-1). Moreover, ECs growing on nano/micro-combined scaf-
folds exhibited a marked angiogenic potential as shown by their
ability to form extensive networks of capillary-like structures.Acknowledgements
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